Ian F Parney Selected Research

Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))

1/2022	Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.
1/2019	Isolation and Analysis of Plasma-Derived Exosomes in Patients With Glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ian F Parney Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 02/2002
33	Glioma (Gliomas) 01/2022 - 02/2002
30	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 02/2002
17	Brain Neoplasms (Brain Tumor) 09/2022 - 05/2002
4	Astrocytoma (Pilocytic Astrocytoma) 10/2014 - 11/2012
3	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2017
3	Brain Injuries (Brain Injury) 01/2020 - 10/2013
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 10/2013
3	Melanoma (Melanoma, Malignant) 12/2016 - 05/2002
2	Medulloblastoma 01/2022 - 02/2014
2	Hemorrhage 01/2019 - 10/2018
2	Critical Illness (Critically Ill) 10/2013 - 10/2013
2	Inflammation (Inflammations) 10/2013 - 02/2002
1	Residual Neoplasm 01/2022
1	Uveal melanoma 10/2021
1	Primitive Neuroectodermal Tumors (PNET) 01/2021
1	Meningioma (Meningiomas) 09/2020
1	Acoustic Neuroma (Acoustic Neurinoma) 10/2019
1	Surgical Wound Infection 01/2019
1	Pulmonary Embolism 01/2019
1	Venous Thromboembolism 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019
1	Postoperative Hemorrhage 01/2019
1	Infections 10/2018
1	Hematologic Neoplasms (Hematological Malignancy) 10/2018
1	Retinal Detachment (Retinal Detachments) 01/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017
1	Macular Edema 01/2017
1	Brain Diseases (Brain Disorder) 01/2017
1	Neuroblastoma 04/2016

Drug/Important Bio-Agent (IBA)

10	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 09/2009
6	VaccinesIBA 01/2020 - 05/2002
6	AntigensIBA 01/2020 - 11/2011
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2005
4	Pharmaceutical PreparationsIBA 12/2021 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2018
3	Neoplasm Antigens (Tumor Antigens)IBA 04/2016 - 01/2003
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2006 - 05/2002
3	Interleukin-12 (IL 12)IBA 08/2002 - 02/2002
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 01/2019
2	Untranslated RNA (Noncoding RNA)IBA 01/2022 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 12/2021 - 01/2020
2	CarbonIBA 10/2021 - 12/2016
2	TensinsIBA 01/2020 - 01/2007
2	Biological ProductsIBA 01/2019 - 02/2005
2	Phenylalanine (L-Phenylalanine)FDA Link 05/2018 - 08/2013
2	GadoliniumIBA 01/2018 - 01/2015
2	Matrix Metalloproteinases (MMPs)IBA 10/2013 - 10/2013
2	CytokinesIBA 10/2013 - 02/2002
2	Amino Acids FDA Link 08/2013 - 01/2013
2	fluorodopa F 18IBA 08/2013 - 01/2013
2	InterleukinsIBA 02/2005 - 02/2002
1	MicroRNAs (MicroRNA)IBA 01/2022
1	dipinacoline glutamateIBA 01/2022
1	depatuxizumab mafodotinIBA 12/2021
1	Immunoconjugates (Immunoconjugate)IBA 12/2021
1	TantalumIBA 10/2021
1	Nylons (Nylon)IBA 10/2021
1	pembrolizumabIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	SteroidsIBA 12/2020
1	LuciferasesIBA 01/2020
1	LigandsIBA 01/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020
1	Platelet-Derived Growth FactorIBA 01/2020
1	epidermal growth factor receptor VIIIIBA 01/2020
1	B7-H1 AntigenIBA 10/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019
1	pyrazoleIBA 01/2019
1	vinyltriethoxysilane (VTES)IBA 01/2019
1	Vancomycin FDA LinkGeneric 01/2019
1	InterferonsIBA 10/2018
1	Janus Kinase InhibitorsIBA 10/2018
1	Bevacizumab (Avastin)FDA Link 10/2018
1	ruxolitinibIBA 10/2018
1	SAR405838IBA 01/2018
1	Blocking AntibodiesIBA 01/2018
1	O-(6)-methylguanineIBA 10/2017
1	MethyltransferasesIBA 10/2017
1	sulforaphaneIBA 01/2017
1	Conditioned Culture MediaIBA 01/2017
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 06/2016
1	Cytochromes c (Cytochrome c)IBA 04/2016

Therapy/Procedure

20	Therapeutics 09/2022 - 05/2002
15	Immunotherapy 01/2021 - 02/2002
14	Radiotherapy 10/2021 - 04/2007
6	Drug Therapy (Chemotherapy) 01/2022 - 05/2003
3	Craniotomy 01/2019 - 06/2003
2	Chemoradiotherapy 09/2009 - 08/2008
1	Lasers (Laser) 09/2022
1	Sutures (Suture) 10/2021
1	Adjuvant Radiotherapy 09/2020
1	Chemoprevention 01/2019
1	Length of Stay 10/2018
1	Reoperation 10/2018
1	Oncolytic Virotherapy 10/2018
1	Neurosurgical Procedures 01/2018
1	Traction 01/2017